Literature DB >> 7914727

Conformation of the transmembrane domain of the epidermal growth factor receptor.

P W Brandt-Rauf1, R Monaco, M R Pincus.   

Abstract

The transmembrane domain of growth factor receptors, such as the epidermal growth factor receptor (EGFR) and the related c-erbB-2/neu oncogene protein, has been implicated in the process of receptor dimerization and mitogenic signal transduction, and hence in cellular transformation and oncogenesis. Amino acid substitutions in the transmembrane domain of the c-erbB-2/neu protein that cause a transforming effect may exert this effect through a conformational change from a bend conformation to an alpha-helical structure in this region of the protein, but similar amino acid substitutions at homologous positions in the transmembrane domain of the EGFR (e.g., Val-->Glu at position 627) fail to have a transforming effect. To examine whether this failure may be due to structural effects, we have used conformational energy analysis to determine the preferred three-dimensional structures for the nonapeptide sequence of the transmembrane domain of the EGFR from residues 623-631 with Val or Glu at position 627. The global minimum energy conformations of both nonapeptides were found to be non-alpha-helical with bends at positions 624-625 and 627-628. The failure of the Val-->Glu substitution to produce a conformational change to an alpha-helix in this region may be responsible for its lack of transforming effect. However, the presence of higher energy alpha-helical conformations for the nonapeptide from the normal EGFR may provide an explanation for the presence of a transforming effect from overexpression of the EGFR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914727     DOI: 10.1007/bf01891980

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  20 in total

Review 1.  Pathways for activation of the ras-oncogene-encoded p21 protein.

Authors:  M R Pincus; D Chung; D C Dykes; P Brandt-Rauf; I B Weinstein; Z Yamaizumi; S Nishimura
Journal:  Ann Clin Lab Sci       Date:  1992 Sep-Oct       Impact factor: 1.256

Review 2.  Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.

Authors:  W J Gullick
Journal:  Br Med Bull       Date:  1991-01       Impact factor: 4.291

Review 3.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 4.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

5.  Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.

Authors:  P W Brandt-Rauf; M R Pincus; J M Chen
Journal:  J Protein Chem       Date:  1989-12

6.  Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.

Authors:  O Segatto; C R King; J H Pierce; P P Di Fiore; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

7.  Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP.

Authors:  S S Zimmerman; M S Pottle; G Némethy; H A Scheraga
Journal:  Macromolecules       Date:  1977 Jan-Feb       Impact factor: 5.985

8.  Conformational effects of selected cancer-related amino acid substitutions in the p53 protein.

Authors:  P W Brandt-Rauf; I De Vivo; D C Dykes; M R Pincus
Journal:  J Biomol Struct Dyn       Date:  1992-10

9.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

10.  Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.

Authors:  C I Bargmann; R A Weinberg
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  2 in total

1.  Structural implications of a Val-->Glu mutation in transmembrane peptides from the EGF receptor.

Authors:  S Sharpe; C W Grant; K R Barber; J Giusti; M R Morrow
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.

Authors:  P W Brandt-Rauf; M R Pincus; R Monaco
Journal:  J Protein Chem       Date:  1995-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.